Atlas Trials

Safety and Immunogenicity Study of an Inactivated SARS-CoV-2 Vaccine for Preventing Against COVID-19 in People Aged ⩾60 Years

Clinical trial NCT04470609 · COMPLETED

Trial details

NCT number
NCT04470609
Sponsor
Institute of Medical Biology, Chinese Academy of Medical Sciences
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
COVID-19
Start date
2020-07-10
Primary completion
2020-10-30
Enrollment
471

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.